Improved overall survival over recent decades in patients with hormone-receptor-positive, HER2-negative breast cancer: a single-center retrospective analysis of prognostic factors.

Conclusions: The prognosis for HR-positive HER2-negative BC patients after surgical therapy has improved, resulting in longer OS and RFS across the study periods. These changes could be associated with early detection of tumor and history of hormone therapy. PMID: 29385493 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29385493?dopt=Abstract

Source: Clinical Genitourinary Cancer - January 29, 2018 Category: Cancer & Oncology Authors: Yamada Y, Mukai H, Tokudome Y, Kaneko M, Kashiwabara K, Wada N Tags: Jpn J Clin Oncol Source Type: research